{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T19:25:54Z","timestamp":1777317954810,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,4,26]],"date-time":"2015-04-26T00:00:00Z","timestamp":1430006400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s10067-015-2940-z","type":"journal-article","created":{"date-parts":[[2015,4,25]],"date-time":"2015-04-25T04:13:51Z","timestamp":1429935231000},"page":"1085-1089","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Changes of serum levels of MMP-3, sRANKL, and OPG in juvenile-onset ankylosing spondylitis patients carrying different HLA-B27 subtypes"],"prefix":"10.1007","volume":"34","author":[{"given":"Yi-Kun","family":"Mou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping-Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu-Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Ming","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ze-Tao","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu-Jing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie-Ruo","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,26]]},"reference":[{"issue":"3","key":"2940_CR1","first-page":"131","volume":"3","author":"GY Shi","year":"1999","unstructured":"Shi GY (1999) Early clinical characteristic of juvenile-onset spondyloarthropathies. Chin J Rheumatol 3(3):131\u2013132","journal-title":"Chin J Rheumatol"},{"issue":"22","key":"2940_CR2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1726-4901(09)70432-0","volume":"72","author":"YC Lin","year":"2009","unstructured":"Lin YC, Liang TH, Chen WS et al (2009) Differences between juvenile-onset ankylosing spondylitis and adult-onset ankylosing spondylitis. J Chin Med Assoc 72(22):573\u2013580","journal-title":"J Chin Med Assoc"},{"issue":"3","key":"2940_CR3","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/art.21174","volume":"53","author":"M Stone","year":"2005","unstructured":"Stone M, Warren RW, Bruckel J et al (2005) Juvenile-onset ankylosing spondylitis is associated with worse functional outcomes than adult-onset ankylosing spondylitis. Arthritis Rheum 53(3):445\u2013451","journal-title":"Arthritis Rheum"},{"issue":"4","key":"2940_CR4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10067-010-1538-8","volume":"30","author":"MA Weijden van der","year":"2011","unstructured":"van der Weijden MA, van Denderen JC, Lems WF et al (2011) Low bone mineral density is related to male gender and decreased functional capacity in early spondylarthropathies. Clin Rheumatol 30(4):497\u2013503","journal-title":"Clin Rheumatol"},{"issue":"2","key":"2940_CR5","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00223-014-9867-2","volume":"95","author":"J Bao","year":"2014","unstructured":"Bao J, Chen Y, Bao YX (2014) Prevalence and risk factors of low bone mineral density in juvenile onset ankylosing spondylitis. Calcif Tissue Int 95(2):108\u2013111","journal-title":"Calcif Tissue Int"},{"key":"2940_CR6","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/rheumatology\/kei208","volume":"45","author":"CH Chen","year":"2006","unstructured":"Chen CH, Lin KC, Yu DT et al (2006) Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity. Rheumatology 45:414\u2013420","journal-title":"Rheumatology"},{"issue":"11","key":"2940_CR7","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.3899\/jrheum.110352","volume":"38","author":"V Viswanath","year":"2011","unstructured":"Viswanath V, Myles A, Dayal R et al (2011) Levels of serum matrix metalloproteinase-3 correlate with disease activity in the enthesitis-related arthritis category of juvenile idiopathic arthritis. J Rheumatol 38(11):2482\u20132487","journal-title":"J Rheumatol"},{"issue":"6","key":"2940_CR8","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1002\/art.22589","volume":"56","author":"WP Maksymowych","year":"2007","unstructured":"Maksymowych WP, Landew\u00e9 R, Conner-Spady B et al (2007) Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis. Arthritis Rheum 56(6):1846\u20131853","journal-title":"Arthritis Rheum"},{"issue":"9","key":"2940_CR9","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1002\/art.20477","volume":"50","author":"B Vandooren","year":"2004","unstructured":"Vandooren B, Kruithof E, Yu DT et al (2004) Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy. Arthritis Rheum 50(9):2942\u20132953","journal-title":"Arthritis Rheum"},{"issue":"3","key":"2940_CR10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10067-007-0701-3","volume":"27","author":"PK Sarma","year":"2008","unstructured":"Sarma PK, Misra R, Aggarwal A (2008) Elevated serum receptor activator of NF kappaB ligand (RANKL), osteoprotegerin (OPG), matrix metalloproteinase (MMP)3, and ProMMP1 in patients with juvenile idiopathic arthritis. Clin Rheumatol 27(3):289\u2013294","journal-title":"Clin Rheumatol"},{"key":"2940_CR11","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1161\/01.CIR.0000165119.62099.14","volume":"111","author":"U Thor","year":"2005","unstructured":"Thor U, Arne Y, \u00d8ie E et al (2005) Dysregulated osteoprotegerin\/RANK ligand\/RANK axis in clinical and experimental heart failure. Circulation 111:2461\u20132468","journal-title":"Circulation"},{"key":"2940_CR12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/01.bor.0000231912.24740.a5","volume":"18","author":"K Sato","year":"2006","unstructured":"Sato K, Takayanagi H (2006) Osteoclasts, rheumatoid arthritis, and osteoimmunology. Curr Opin Rheumatol 18:419\u2013426","journal-title":"Curr Opin Rheumatol"},{"key":"2940_CR13","first-page":"427","volume":"18","author":"BF Boyce","year":"2006","unstructured":"Boyce BF, Schwarz EM, Xing LP (2006) Osteoclast precursors: cytokine-stimulated immunomodulators of inflammatory bone disease. CurrOpin Rheumatol 18:427\u2013432","journal-title":"CurrOpin Rheumatol"},{"key":"2940_CR14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10654-011-9555-8","volume":"26","author":"J Lone","year":"2011","unstructured":"Lone J, John-Bjarne H, Jan B et al (2011) Serum osteoprotegerin levels are related to height loss: the Troms\u00f8 Study. Eur J Epidemiol 26:305\u2013312","journal-title":"Eur J Epidemiol"},{"key":"2940_CR15","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/ard.61.12.1047","volume":"61","author":"TN Crotti","year":"2002","unstructured":"Crotti TN, Smith MD, Weedon H et al (2002) Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis. Ann Rheum Dis 61:1047\u20131054","journal-title":"Ann Rheum Dis"},{"key":"2940_CR16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/rheumatology\/keg047","volume":"42","author":"DR Haynes","year":"2003","unstructured":"Haynes DR, Barg E, Crotti TN et al (2003) Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls. Rheumatology 42:123\u2013134","journal-title":"Rheumatology"},{"key":"2940_CR17","first-page":"1184","volume":"32","author":"D Wendling","year":"2005","unstructured":"Wendling D (2005) Bone loss in AS: can we put the puzzle together? J Rheumatol 32:1184\u20131185","journal-title":"J Rheumatol"},{"key":"2940_CR18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/ard.2006.058313","volume":"66","author":"W Lems","year":"2007","unstructured":"Lems W (2007) Clinical relevance of vertebral fractures: why are vertebral fractures so often overlooked? Ann Rheum Dis 66:2\u20134","journal-title":"Ann Rheum Dis"},{"key":"2940_CR19","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1399-0039.2009.01406.x","volume":"75","author":"Y Mou","year":"2010","unstructured":"Mou Y, Wu Z, Gu J, Liao Z et al (2010) HLA-B27 polymorphism in patients with juvenile and adult-onset ankylosing spondylitis in Southern China. Tissue Antigens 75:56\u201360","journal-title":"Tissue Antigens"},{"issue":"4","key":"2940_CR20","first-page":"270","volume":"4","author":"GU Jie-ruo","year":"2004","unstructured":"Jie-ruo GU, Han-wei ZHANF, Li-ke ZHAO et al (2004) The significance of matrix metalloproteinase-3 response down-regulation in the treatment of ankylosing spondylitis by anti-TNF-a monoclonal antibody remicade. Chin Rem Clin 4(4):270\u2013276","journal-title":"Chin Rem Clin"},{"issue":"11","key":"2940_CR21","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.3899\/jrheum.110352","volume":"38","author":"V Viswanath","year":"2011","unstructured":"Viswanath V, Myles A, Dayal R et al (2011) Levels of serum matrix metalloproteinase-3 correlate with disease activity in the enthesitis-related arthritis category of juvenile idiopathic arthritis. J Rheumatol 38(11):2482\u20132487","journal-title":"J Rheumatol"},{"key":"2940_CR22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W","volume":"43","author":"H Takayanagi","year":"2000","unstructured":"Takayanagi H, Iizuka H, Juji T et al (2000) Involvement of receptor activator of nuclear factor\u03baB ligand osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum 43:259\u2013269","journal-title":"Arthritis Rheum"},{"key":"2940_CR23","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/art.10168","volume":"46","author":"JM Dayer","year":"2002","unstructured":"Dayer JM, Bresnihan B (2002) Targeting interleukin 1 in the treatment of rheumatoid arthritis. Arthritis Rheum 46:574\u2013578","journal-title":"Arthritis Rheum"},{"issue":"3","key":"2940_CR24","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00109-004-0612-6","volume":"83","author":"H Takayanagi","year":"2005","unstructured":"Takayanagi H (2005) Mechanistic insight into osteoclast differentiation in osteoimmunology. J Mol Med 83(3):170\u2013179","journal-title":"J Mol Med"},{"issue":"47","key":"2940_CR25","doi-asserted-by":"crossref","first-page":"20281","DOI":"10.1073\/pnas.1011686107","volume":"107","author":"HM Ta","year":"2010","unstructured":"Ta HM, Nguyen GT, Jin HM et al (2010) Structure-based development of a receptor activator of nuclear factor-kappaB ligand (RANKL) inhibitor peptide and molecular basis for osteopetrosis. Proc Natl Acad Sci U S A 107(47):20281\u201320286","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2940_CR26","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1007\/s00296-011-2066-9","volume":"32","author":"S Grazio","year":"2012","unstructured":"Grazio S, Kusi\u0107 Z, Cvijeti\u0107 S et al (2012) Relationship of bone mineral density with disease activity and functional ability in patients with ankylosing spondylitis: a cross-sectional study. Rheumatol Int 32(9):2801\u20132808","journal-title":"Rheumatol Int"},{"issue":"4","key":"2940_CR27","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10067-010-1538-8","volume":"30","author":"MA Weijden Van der","year":"2011","unstructured":"Van der Weijden MA, van Denderen JC, Lems WF et al (2011) Low bone mineral density is related to male gender and decreased functional capacity in early spondylarthropathies. Clin Rheumatol 30(4):497\u2013503","journal-title":"Clin Rheumatol"},{"issue":"5","key":"2940_CR28","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00198-010-1338-7","volume":"22","author":"S Arends","year":"2011","unstructured":"Arends S, Spoorenberg A, Bruyn GA et al (2011) The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis. Osteoporos Int 22(5):1431\u20131439","journal-title":"Osteoporos Int"},{"issue":"11","key":"2940_CR29","first-page":"2236","volume":"31","author":"H Franck","year":"2004","unstructured":"Franck H, Meurer T, Hofbauer LC (2004) Evaluation of bone mineral density, hormones, biochemical markers of bone metabolism, and osteoprotegerin serum levels in patients with ankylosing spondylitis. J Rheumatol 31(11):2236\u20132241","journal-title":"J Rheumatol"},{"key":"2940_CR30","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/rheumatology\/kel072","volume":"45","author":"HR Kim","year":"2006","unstructured":"Kim HR, Lee SH, Kim HY (2006) Elevated serum levels of soluble receptor activator of nuclear factors-kappaB ligand (sRANKL) and reduced bone mineral density in patients with ankylosing spondylitis (AS). Rheumatology 45:1197\u20131200","journal-title":"Rheumatology"},{"issue":"6","key":"2940_CR31","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/jbmr.2170","volume":"29","author":"S T\u00e9letch\u00e9a","year":"2014","unstructured":"T\u00e9letch\u00e9a S, Stresing V, Hervouet S et al (2014) Novel RANK antagonists for the treatment of bone-resorptive disease: theoretical predictions and experimental validation. J Bone Miner Res 29(6):1466\u201377","journal-title":"J Bone Miner Res"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-015-2940-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-015-2940-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-015-2940-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T03:08:26Z","timestamp":1566616106000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-015-2940-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,26]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["2940"],"URL":"https:\/\/doi.org\/10.1007\/s10067-015-2940-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,26]]}}}